LCIP
ABBV icon

Life Cycle Investment Partners’s AbbVie ABBV Stock Holding History

Life Cycle Investment Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$136M Sell
542,382
-180,466
-25% -$38.8M 0.64% 37
2026
Q1 		$157M Buy
722,848
+242,206
+50% +$53.7M 1% 28
2025
Q4 		$110M Buy
+480,642
New +$109M 0.77% 30

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Life Cycle Investment Partners's ABBV Position: Q2 2026 in Review

Life Cycle Investment Partners reduced its AbbVie (ABBV) stake by 25% in Q2 2026, selling an estimated $38.8M and leaving 542,382 shares worth $136M. The position accounts for 0.64% of the portfolio, ranked #37.

Life Cycle Investment Partners first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $157M in Q1 2026. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Life Cycle Investment Partners held 542,382 shares of AbbVie worth $136M as of Q2 2026.
  • Life Cycle Investment Partners sold 180,466 AbbVie shares in Q2 2026, an estimated $38.8M.
  • AbbVie made up 0.64% of Life Cycle Investment Partners's portfolio in Q2 2026, its #37 holding.
  • Life Cycle Investment Partners first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • Life Cycle Investment Partners's AbbVie position peaked at $157M in Q1 2026.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Life Cycle Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.